Abstract
A man with chronic progressive multiple sclerosis received a 10 day course of treatment with adrenocorticotrophic hormone without beneficial effect. He then received six sessions of plasmapheresis, again without improvement. Treatment with adrenocorticotrophic hormone had no effect on serum antibrain antibody titres, but plasmapheresis virtually eliminated the antibodies from serum and caused a fall in serum IgG concentrations; neither treatment had any effect on the IgG concentration and antibody titre in the cerebrospinal fluid. Treatment with plasmapheresis may fail in patients with multiple sclerosis because it does not remove antibrain antibodies from the intrathecal space.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ryberg B. Antibrain antibodies in multiple sclerosis. Relation to clinical variables. J Neurol Sci. 1982 May;54(2):239–261. doi: 10.1016/0022-510x(82)90185-x. [DOI] [PubMed] [Google Scholar]
- Shumak K. H., Rock G. A. Therapeutic plasma exchange. N Engl J Med. 1984 Mar 22;310(12):762–771. doi: 10.1056/NEJM198403223101206. [DOI] [PubMed] [Google Scholar]
- Stefoski D., Schauf C. L., McLeod B. C., Haywood C. P., Davis F. A. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis. Neurology. 1982 Aug;32(8):904–907. doi: 10.1212/wnl.32.8.904. [DOI] [PubMed] [Google Scholar]